Clinical Trial Update: Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether cariprazine affects cardiac repolarization in patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Cariprazine (Vraylar) (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED